Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

被引:289
作者
Thomas, CE
Storm, TA
Huang, Z
Kay, MA
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
关键词
D O I
10.1128/JVI.78.6.3110-3122.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Transduction of the liver with single-stranded adeno-associated virus serotype 2 (AAV2) vectors is inefficient; less than 10% of hepatocytes are permissive for stable transduction, and transgene expression is characterized by a lag phase of up to 6 weeks. AAV2-based vector genomes packaged inside AAV6 or AAV8 capsids can transduce the liver with higher efficiency, but the molecular mechanisms underlying this phenomenon have not been determined. We now show that the primary barrier to transduction of the liver with vectors based on AAV2 capsids is uncoating of vector genomes in the nucleus. The majority of AAV2 genomes persist as encapsidated single-stranded molecules within the nucleus for as long as 6 weeks after vector administration. Double-stranded vector genomes packaged inside AAV2 capsids are at least 50-fold more active than single-stranded counterparts, but these vectors also exhibit a lag phase before maximal gene expression. Vector genomes packaged inside AAV6 or AAV8 capsids do not persist as encapsidated molecules and are more biologically active than vector genomes packaged inside AAV2 capsids. Our data suggest that the rate of uncoating of vector genomes determines the ability of complementary plus and minus single-stranded genomes to anneal together and convert to stable, biologically active double-stranded molecular forms.
引用
收藏
页码:3110 / 3122
页数:13
相关论文
共 34 条
[31]   Safety and biological efficacy of an adeno-associated virus vector cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus [J].
Wagner, JA ;
Messner, AH ;
Moran, ML ;
Daifuku, R ;
Kouyama, K ;
Desch, JK ;
Manley, S ;
Norbash, AM ;
Conrad, CK ;
Friborg, S ;
Reynolds, T ;
Guggino, WB ;
Moss, RB ;
Carter, BJ ;
Wine, JJ ;
Flotte, TR ;
Gardner, P .
LARYNGOSCOPE, 1999, 109 (02) :266-274
[32]   Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2 [J].
Xiao, W ;
Warrington, KH ;
Hearing, P ;
Hughes, J ;
Muzyczka, N .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11505-11517
[33]   Adeno-associated virus as a vector for liver-directed gene therapy [J].
Xiao, WD ;
Berta, SC ;
Lu, MM ;
Moscioni, AD ;
Tazelaar, J ;
Wilson, JM .
JOURNAL OF VIROLOGY, 1998, 72 (12) :10222-10226
[34]   Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors [J].
Yan, ZY ;
Zak, R ;
Luxton, GWG ;
Ritchie, TC ;
Bantel-Schaal, U ;
Engelhardt, JF .
JOURNAL OF VIROLOGY, 2002, 76 (05) :2043-2053